Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00733 | MC-vc-PAB-C6-a-amanitin | |
| MC-vc-PAB-C6-a-amanitin is a drug-linker conjugate for ADC by using a-amanitin (a potent bicyclic octapeptide cytotoxin), linked via MC-vc-PAB-C6. | Inquiry | |
| BADC-00734 | MC-vc-PAB-DMEA-(PEG2)-duocarmycin SA | |
| MC-vc-PAB-DMEA-(PEG2)-duocarmycin SA is a drug-linker conjugate for ADC by using Duocarmycin SA (a potent antitumor antibiotic), linked via MC-vc-PAB-DMEA-(PEG2). | Inquiry | |
| BADC-00736 | MC-va-PAB-MMAD | |
| MC-va-PAB-MMAD is a drug-linker conjugate for ADC by using Monomethyl Dolastatin 10 (MMAD, a potent tubulin inhibitor), linked via MC-va-PAB. | Inquiry | |
| BADC-00737 | MA-PEG4-VC-PAB-DMEA-PNU159682 | 2259318-52-8 |
| MA-PEG4-VC-PAB-DMEA-PNU159682 is a drug-linker conjugate for ADC by using PNU159682 (a potent DNA topoisomerase II inhibitor), linked via MA-PEG4-VC-PAB-DMEA. | Inquiry | |
| BADC-00738 | MA-PEG4-VA-PBD | 1342820-68-1 |
| MA-PEG4-VA-PBD is a drug-linker conjugate for ADC by using PBD (Pyrrolobenzodiazepine dimers, a potent antitumor antibiotic), linked via MA-PEG4-VA. | Inquiry | |
| BADC-00739 | MC-vc-PAB-MMAD | |
| MC-vc-PAB-MMAD is a drug-linker conjugate for ADC by using Monomethyl Dolastatin 10 (MMAD, a potent tubulin inhibitor), linked via MC-vc-PAB. | Inquiry | |
| BADC-00740 | MC-vc-PAB-Auristatin 0101 | |
| MC-vc-PAB-Auristatin 0101 is a drug-linker conjugate for ADC by using Auristatin 0101 (an auristatin microtubule inhibitor), linked via MC-vc-PAB. | Inquiry | |
| BADC-00741 | MA-PEG8-VA-PAB-SG3199 | |
| MA-PEG8-VA-PAB-SG3199 is a drug-linker conjugate for ADC by using SG3199 (a PBD dimer,has a potently cytotoxic against cancer cell lines), linked via MA-PEG8-VA-PAB. | Inquiry | |
| BADC-00742 | CL2A-SN 38 | 1279680-68-0 |
| CL2A-SN 38 is a drug-linker conjugate for ADC by using SN 38 (a DNA Topoisomerase I inhibitor), linked via CL2A. | Inquiry | |
| BADC-00743 | MA-PEG4-vc-PAB-DMEA-duocarmycin TM | |
| MA-PEG4-vc-PAB-DMEA-duocarmycin TM is a drug-linker conjugate for ADC by using Duocarmycin TM (a potent antitumor antibiotic), linked via MA-PEG4-vc-PAB-DMEA. | Inquiry | |
| BADC-00744 | MC-vc-PAB-(PEG2)-duocarmycin TM | |
| MC-vc-PAB-(PEG2)-duocarmycin TM is a drug-linker conjugate for ADC by using Duocarmycin TM (a potent antitumor antibiotic), linked via MA-MC-vc-PAB-(PEG2). | Inquiry | |
| BADC-00745 | MA-PEG4-vc-PAB-DMEA-duocarmycin DM | |
| MA-PEG4-vc-PAB-DMEA-duocarmycin DM is a drug-linker conjugate for ADC by using Duocarmycin DM (a potent antitumor antibiotic), linked via MA-PEG4-vc-PAB-DMEA. | Inquiry | |
| BADC-00746 | MC-vc-PAB-(PEG2)-duocarmycin DM | |
| MC-vc-PAB-(PEG2)-duocarmycin DM is a drug-linker conjugate for ADC by using Duocarmycin DM (a potent antitumor antibiotic), linked via MA-MC-vc-PAB-(PEG2). | Inquiry | |
| BADC-00747 | DGN549 | |
| DGN549 is a drug-linker conjugate for ADC. | Inquiry | |
| BADC-00748 | MPB-vc-PAB-MMAE | |
| MPB-vc-PAB-MMAE is a drug-linker conjugate for ADC by using monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via MPB-vc-PAB. | Inquiry | |
| BADC-00749 | MPB-MMAF | |
| MPB-MMAF is a drug-linker conjugate for ADC by using Monomethylauristatin F (MMAF,a potent tubulin polymerization inhibitor), linked via MPB. | Inquiry | |
| BADC-00751 | DBCO-PEG4-MMAF | 2360411-65-8 |
| DBCO-PEG4-MMAF is a drug-linker conjugate for ADC by using Monomethylauristatin F (MMAF,a potent tubulin polymerization inhibitor), linked via DBCO-PEG4. | Inquiry | |
| BADC-00752 | DBCO-PEG4-Ahx-DM1 | |
| DBCO-PEG4-Ahx-DM1 is a drug-linker conjugate for ADC by using DM1 (Maytansinoid DM1, a microtubulin inhibitor), linked via DBCO-PEG4-Ahx. | Inquiry | |
| BADC-00753 | DBCO-PEG4-vc-PAB-Duocarmycin SA | |
| DBCO-PEG4-vc-PAB-Duocarmycin SA is a drug-linker conjugate for ADC by using Duocarmycin SA (a potent antitumor antibiotic), linked via DBCO-PEG4-vc-PAB. | Inquiry | |
| BADC-00754 | DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin SA | |
| DBCO-PEG4-vc-PAB-(PEG2)-Duocarmycin SA is a drug-linker conjugate for ADC by using Duocarmycin SA (a potent antitumor antibiotic), linked via DBCO-PEG4-vc-PAB-(PEG2). | Inquiry |
